Cart
sales@molnova.com
CPCCOEt
CAS No. 179067-99-3
CPCCOEt( —— )
Catalog No. M33842 CAS No. 179067-99-3
CPCCOEt is a low-affinity, selective, non-competitive, and reversible antagonist of mGluR1b.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 46 | In Stock |
|
| 5MG | 46 | In Stock |
|
| 10MG | 64 | In Stock |
|
| 25MG | 129 | In Stock |
|
| 50MG | 207 | In Stock |
|
| 100MG | 306 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCPCCOEt
-
NoteResearch use only, not for human use.
-
Brief DescriptionCPCCOEt is a low-affinity, selective, non-competitive, and reversible antagonist of mGluR1b.
-
DescriptionCPCCOEt is a low affinity, selective, non-competitive and reversible antagonist ofmetabotropic glutamate receptor 1b (mGluR1b).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayNeuroscience
-
TargetGluR
-
RecptorGluR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number179067-99-3
-
Formula Weight247.25
-
Molecular FormulaC13H13NO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (404.45 mM; Ultrasonic )
-
SMILESCCOC(=O)C12CC1\C(=N/O)c1ccccc1O2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Litschig S, et al. CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding. Mol Pharmacol. 1999 Mar;55(3):453-61.??
molnova catalog
related products
-
Dipraglurant
Dipraglurant (ADX48621) is a negative alteration modulator (NAM) of mGluR5 that inhibits dyskinesia in the LID macaque model.
-
GYKI 52466 dihydroch...
GYKI 52466 dihydrochloride (GYKI 52466 2HCl) is a highly potent, orally active and selective AMPA/Kainate receptor antagonist with good blood-brain permeability and anticonvulsant activity that can be used to study neurological diseases such as Parkinson's and epilepsy.
-
NS-102
NS-102 is a glutamate receptor and NMDA receptor antagonist that inhibits erythrocyanine (GluK2), which reduces glur6 receptor-mediated currents, and inhibits specific binding to the glur6 receptor.
